Tandem Diabetes Care Announces Upcoming Conference Presentations

Rhea-AI Summary

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) will present updates at several investor conferences in November 2022. The presentations will take place at the Credit Suisse 31st Annual Healthcare Conference on November 8 at 4:25 PM ET, the Jefferies London Healthcare Conference on November 15 at 12:20 PM GMT, and the Stifel 2022 Healthcare Conference on November 16 at 4:45 PM ET. All presentations will be webcast live with an archive available for 30 days on their Investor Center website.

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:

• Credit Suisse 31^st Annual Healthcare Conference on Tuesday, November 8, 2022 at 4:25pm ET (1:25pm PT),
• Jefferies London Healthcare Conference on Tuesday, November 15, 2022 at 12:20pm GMT (7:20am ET, 4:20am PT), and
• Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 at 4:45pm ET (1:45pm PT).

The Company update presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2 and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221027005671/en/

Media Contact:

Steve Sabicer

714-907-6264

ssabicer@thesabicergroup.com

Investor Contact:

Susan Morrison

858-366-6900

IR@tandemdiabetes.com

Source: Tandem Diabetes Care, Inc.

FAQ

When will Tandem Diabetes Care present at the Credit Suisse Healthcare Conference?

Tandem Diabetes Care will present at the Credit Suisse 31st Annual Healthcare Conference on November 8, 2022, at 4:25 PM ET.

What is the schedule for Tandem Diabetes Care's investor presentations in November 2022?

Tandem Diabetes Care will present at the Jefferies London Healthcare Conference on November 15, 2022, at 12:20 PM GMT, and at the Stifel 2022 Healthcare Conference on November 16, 2022, at 4:45 PM ET.

Where can I watch Tandem Diabetes Care's conference presentations?

Tandem Diabetes Care's presentations will be webcast live, with archives available for 30 days on their Investor Center website.

What is the significance of Tandem Diabetes Care's updates in November 2022?

The updates are crucial for investors to understand the company's strategic direction and innovations in insulin delivery and diabetes technology.

What technology does Tandem Diabetes Care offer?

Tandem Diabetes Care offers the t:slim X2 insulin pump featuring Control-IQ technology.